Yujiro Hata

(Mr. Yujiro Hata)

Currently holds positions in IDEAYA Biosciences Inc and Xencor Inc

Positions

Position Company Period
Chief Executive Officer, Co-Founder, Director IDEAYA Biosciences Inc None -
Independent Director Xencor Inc July 31, 2015 -
Chief Operating Officer Rapt Therapeutics Inc None -
Senior VP, Business Development Enanta Pharmaceuticals Inc None -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-05-16 2024-05-16 PS Planned sale
4,349 -0.6%
42.37
USD 184,250
4,349 -0.6% 42.37 USD 184,250
2024-05-16 2024-05-16 PS Planned sale
30,084 -4.2%
41.73
USD 1,255,505
30,084 -4.2% 41.73 USD 1,255,505
2024-05-16 2024-05-15 PS Planned sale
503 -0.1%
44.12
USD 22,191
503 -0.1% 44.12 USD 22,191
2024-05-16 2024-05-15 PS Planned sale
29,761 -4.2%
43.48
USD 1,293,934
29,761 -4.2% 43.48 USD 1,293,934
2024-05-16 2024-05-15 PS Planned sale
53,592 -7.0%
42.57
USD 2,281,631
53,592 -7.0% 42.57 USD 2,281,631
2024-05-16 2024-05-14 PS Planned sale
2,303 -0.3%
41.84
USD 96,348
2,303 -0.3% 41.84 USD 96,348
2024-05-16 2024-05-14 PS Planned sale
54,408 -7.4%
41.60
USD 2,263,433
54,408 -7.4% 41.60 USD 2,263,433
2024-02-12 2024-02-09 PS Planned sale
23,557 -3.4%
45.54
USD 1,072,715
23,557 -3.4% 45.54 USD 1,072,715
2024-02-12 2024-02-08 PS Planned sale
75,815 -10.1%
45.15
USD 3,422,835
75,815 -10.1% 45.15 USD 3,422,835
2024-02-05 2024-02-01 PS Planned sale
4 -0.0%
45.01
USD 180
4 -0.0% 45.01 USD 180
2024-02-05 2024-02-01 PS Planned sale
624 -0.1%
45.00
USD 28,080
624 -0.1% 45.00 USD 28,080
2024-01-17 2024-01-16 PS Planned sale
62,739 -8.5%
40.17
USD 2,519,968
62,739 -8.5% 40.17 USD 2,519,968
2024-01-17 2024-01-12 PS Planned sale
12,261 -1.8%
40.04
USD 490,913
12,261 -1.8% 40.04 USD 490,913
2023-12-19 2023-12-15 PS Planned sale
75,000 -10.0%
35.03
USD 2,627,618
75,000 -10.0% 35.03 USD 2,627,618
// ... existing code ... // ... rest of the file ...